KD Pharma Group

Life Sciences

Global leader in ultra-high-purity omega-3 and specialty lipid ingredients

Überblick

KD Pharma is a leading manufacturer of highly enriched omega‑3 fatty acids and specialty lipid ingredients used in pharmaceuticals and premium nutraceuticals. The company’s unique, patented purification technologies deliver purity levels up to 99%, enabling differentiated efficacy and quality for customers worldwide. With vertical integration across extraction, separation, chemical synthesis, encapsulation, and packaging, KD Pharma ensures consistent quality, reliability, and speed from raw material to finished dosage forms.

Sector

Life Sciences

Investment

2013 (2019)

Location

Bioggio (CH)

Status

Active

Website

-> https://www.kdpharmagroup.com/

Partner with a global omega-3 leader with defenstible technology to accelerate growth, deepen vertical integration (including pharma-grade encapsulation) and expand into adjacent lipid categories and geographies.

Investment Thesis

Unique, patented production technology achieves ultra‑high purity omega‑3 (up to 99%), creating a strong and defensible competitive advantage.
Vertically integrated model from extraction to finished forms supports quality leadership, reliability, and attractive margins.
Strong, non‑cyclical demand across pharmaceutical and premium nutrition applications with favorable regulatory and quality barriers.
Significant runway from geographic expansion, portfolio broadening, and selective M&A.

Value Creation

Broaden KD Pharma’s presence in adjacent lipid categories and technologies through targeted acquisitions.
Expand into medical cannabis and algae-based sourcing and products to diversify inputs and open new end markets.
Deepen the footprint in Asia, with a particular focus on Japan, by building partnerships and local capabilities.
Optimize the product mix toward higher‑margin pharmaceutical APIs and premium supplements while improving yields and cost efficiency.